ACRS

ACLARIS THERAPEUTICS INC

Healthcare | Small Cap

-$0.15

EPS Forecast

$1.48

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.15

Revenue Forecast:

$1.48

EPS Surprise Forecast:

$0.004

Revenue Surprise Forecast:

$0

Post-release price volatility - Very high

Post-release Overnight Move:

±11.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

58%

Probability of beating revenue consensus:

60%

Probability of beating both EPS & revs consensus:

40%

Probability of missing both EPS & revs consensus:

23%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.51

Earnings volatility

EPS standard deviation:

$0.06

Revenue standard deviation:

$2

As % of share price:

1.49% HIGH

As % of market cap:

0.43% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.09

Revenue 95th %ile:

$4

EPS 75th %ile:

-$0.14

Revenue 75th %ile:

$2

EPS 25th %ile:

-$0.17

Revenue 25th %ile:

$1

EPS 5th %ile:

-$0.22

Revenue 5th %ile:

-$1

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$34

Bid-ask per Share:

$0.015